Editor
The Federal Trade Commission unanimously voted Thursday to advise state and federal authorities to disregard its past statements opposing policies that would require pharmacy benefit managers to reveal more about their business practices.
From 2004 to 2014, the FTC published 11 reports and letters discouraging the implementation of disclosure and transparency rules on the basis that sharing such information would hamper competition. These…
